
Eflapegrastim-xnst subcutaneous injection (Rolvedon) reduces infections related to febrile neutropenia in adults with nonmyeloid malignant tumors who are being treated with certain anticancer drugs.
Eflapegrastim-xnst subcutaneous injection (Rolvedon) reduces infections related to febrile neutropenia in adults with nonmyeloid malignant tumors who are being treated with certain anticancer drugs.
The main cause of C. diff infection remains antibiotic use and overuse.
Removing the word ‘risk’ from discussions of HIV PrEP and focusing more on environment and empowerment concerns are beneficial in this patient population.
Any living person with HIV should be screened for hepatitis B and C upon diagnosis, with annual screenings recommended for those with additional risk factors.
Pharmacists on duty decline to dispense the medication to manage COVID-19, raising question about self-determination.
Rezafungin (Rezzayo; Cidara Therapeutics Inc, Melinta Therapeutics LLC) is the first new treatment option approved for individuals with candidemia and invasive candidiasis in more than a decade.
Expert Cmdr. Jennifer Lind, PharmD, MPH, MBA, discussed how her work in the CDC and the USPHS is a unique path for pharmacists interested in public health.
Clinical decision support, packaging changes can help stop errors related to the HIV medication.
Findings from the ongoing Adult Respiratory Syncytial Virus phase 3 trial suggest RSVPreF3 OA vaccine is effective and safe for individuals aged 60 years and older.
Nightlife transmission of COVID-19 affected a larger number of younger individuals but caused fewer household outbreaks in 2020.
Study results indicates that the injectable antiretroviral therapy can benefit patients who are historically underserved and may face treatment barriers, including those with mental illness.
Many laws also allow physicians to decide which information they disclose to guardians or fail to address inadvertent breaches of confidentiality through insurance billing and claims.
Ideally, older patients receive vaccinations by October, but disease activity often peaks in February or March.
Including the ThinPrep Pap Test improves access to the benefits of the human papillomavirus (HPV) assay, which is the only FDA-approved assay that tests for an extended set of HPV types individually.
Case studies highlight questions about shingles.
Letermovir is the only drug approved for prophylaxis of cytomegalovirus (CMV) infection for patients who are CMV-seropositive and have received an allogeneic HSCT.
Under the EUA, the Xpert Mpox test is considered authorized for use in moderately complex point-of-care settings using the GeneXpert Xpress system.
US adults have a slightly stronger preference for fewer adverse events in relation to pediatric COVID-19 vaccination, study results show.
Streptolysin O appears to influence the pathogenesis of Streptococcus group A and direct mutation-mediated virulence in a host.
Despite the large number of prescription products available, nondrug therapies often work just as well.
Prior to the development of vaccines and direct-acting antivirals, hepatitis infections were treated through methods of prevention.
The FDA approved a new azole antifungal for recurrent vulvovaginal candidiasis.
Protect patients by evaluating VIGIV concentration and avoiding tearing of metal flange on vaccine vial.
Research showed that 600 hospital beds filled with patients with severe illness would be enough to reimplement (mask mandates to stop the spread of infection.
Can the profession afford not to retain expanded job roles for technicians in a post-pandemic era?